0
0
If you have been told the cartilage in your knee is worn down, you have probably already asked the obvious question: can knee cartilage grow back?
The answer you usually get is no. That is not a rumour someone invented. The smooth cartilage capping the ends of your bones has almost no blood supply of its own, and blood is how the body delivers repair. A tissue with no blood vessels is a tissue that mends slowly, or barely at all. It became the standard textbook example of something the adult body simply does not rebuild, which is why worn knees get replaced rather than repaired.
A team led by researchers at Stanford Medicine went at the question from the other side. What if the ability to rebuild cartilage never actually left — and something was sitting on top of it?
The protein that piles up as you age
Their target was an enzyme with an unlovely name: 15-PGDH, short for 15-hydroxyprostaglandin dehydrogenase. The researchers call enzymes like this “gerozymes” — proteins that become more plentiful as a body gets older and seem to push tissue toward decline rather than repair.
When they compared cartilage from young mice with cartilage from old mice, the amount of this enzyme had roughly doubled with age.
What 15-PGDH does is break down a molecule called prostaglandin E2, and prostaglandin E2 is one of the signals that tells tissue to get on with repairing itself. So the picture is less “the repair system wore out” and more “the repair signal was being shredded faster and faster as the years went on.”
Block the enzyme, and the signal survives. That was the whole idea.
What happened in the mice
Two experiments, two different questions.
In the first, they gave old mice a drug that blocks 15-PGDH — delivered either as a general injection or straight into the knee joint. Cartilage thickness increased across the joint surfaces. Cartilage that had already been lost to ordinary ageing came back. And it came back as hyaline cartilage, the smooth load-bearing kind that belongs in a joint, not the rougher fibrocartilage scar tissue the body usually settles for when it patches something.
In the second, they injured young mice in a way that mimics an ACL tear — the kind of injury that reliably leads to arthritis later — and treated them twice a week for four weeks. Untreated animals developed osteoarthritis within four weeks. Treated animals were dramatically less likely to. They also moved more normally and put more weight back on the injured leg, which matters, because cartilage you can see on a slide is not the same as a joint that works.
The paper is titled “Inhibition of 15-hydroxy prostaglandin dehydrogenase promotes cartilage regeneration,” and it was published in the journal Science.
It worked on human tissue too — which is not the same as working on humans
This is the part that gets flattened in most retellings, so it is worth being exact.
The team took real human knee cartilage — samples from patients who were having joint replacement surgery, so tissue that was genuinely worn out — and treated it in the lab for one week. The samples showed fewer cells producing 15-PGDH, lower levels of the markers that signal cartilage breaking down, and the beginnings of new articular cartilage.
That is a meaningful result. It is also tissue in a dish, not a person in a clinic. Nobody with arthritis has been treated with this. There is no injection to ask your doctor about, and anyone selling you one is not selling you this.
How early is it, really? Search the public registry of human trials for this enzyme and osteoarthritis and you will find essentially one study — run by a university hospital, listed as not yet recruiting — and it is not a treatment at all. It is an observational study that measures how much 15-PGDH is floating in people’s blood and joint fluid. The honest state of play is that researchers are still at the stage of measuring the thing in humans. Separately, an oral 15-PGDH blocker has cleared early safety testing in healthy volunteers for a different purpose — age-related muscle weakness — and the Stanford team has said they hope that groundwork makes a cartilage trial possible. Hope is the correct word.
The detail that makes this genuinely strange
Here is the part that did not make the headlines, and it is the most interesting thing in the study.
No stem cells were involved.
Almost every regeneration story you have read works on the same premise: the worn-out cells are finished, so you bring in fresh ones. That is the logic behind stem cell injections, and it is why cartilage was considered hopeless — there is no good supply of replacements down there.
That is not what happened here. The cartilage cells already living in those old knees — the same cells that had been quietly failing for the animal’s whole adult life — changed what they were doing. Their gene expression shifted. They went back to building. Nothing was added. Nothing was imported. The capacity was present the entire time in cells that looked, by every reasonable measure, used up.
The researchers described it as a new way of regenerating adult tissue, and that is not marketing language. It is a different answer to a question everyone thought they understood.
If that idea interests you, it is worth knowing it keeps showing up. We wrote about cells that almost died and then rebuilt the tissue around them, and about the heart’s own quiet attempt to regrow after a heart attack. The pattern is consistent enough to be a little unnerving: the equipment is often still in there.
One question the study raises and does not answer
If prostaglandin E2 is the repair signal, it is fair to notice what else lowers prostaglandin E2.
Common anti-inflammatory painkillers work by blocking the enzymes that produce prostaglandins, including prostaglandin E2. That is precisely how they reduce pain and swelling. Researchers have been raising questions about what that means for cartilage for years, and the picture is genuinely unsettled — some studies suggest certain older anti-inflammatories interfere with cartilage’s own repair activity, while more selective ones appear not to.
The Stanford study did not test this. It is a question sitting next to the finding, not a conclusion drawn from it. It is also not a reason to change anything you take — that is a conversation for whoever actually treats your knee, with your actual knee in the room. But it is an honest example of how a finding can quietly complicate something that felt settled.
Why this “breakthrough” might look familiar
One more thing, because it affects how you should read your own feed.
This study went online in late 2025. It has been written up, rewritten, and recirculated through health coverage steadily ever since — the same mice, the same enzyme, the same four weeks — and each fresh wave reads like it happened this week. If you have had the feeling that you have seen this headline before, you probably have.
That is not a knock on the science. It is a reminder that “new” in a headline usually describes the article, not the research. Nothing about the finding got better or worse while it was being recycled. It just got louder.
So can knee cartilage grow back in a person?
Not yet, on purpose, with a drug. That is the honest answer and it will stay the honest answer for some years.
What changed is smaller and more durable than a cure: the assumption. Cartilage was the example people reached for when they wanted to name something permanently gone. It is no longer a good example. The capacity was there; the signal was being destroyed faster than it could be heard.
If your knees hurt today, the useful reading is still the unglamorous kind — we went through what 139 clinical trials actually say about non-drug knee arthritis relief, and the answers there are things you can do this week without waiting for anyone’s trial to open.
What was never actually lost
There is something worth sitting with in the shape of this, and it has very little to do with knees.
The repair was not installed. It was already there. What stood in the way was something that had accumulated quietly over years, nobody chose it, it simply gathered until it was twice the weight it used to be — and when it was lifted, the thing underneath turned out to be intact. Not replaced. Not rebuilt from scratch. Just finally able to do what it had always been able to do.
People have been describing human beings that way for a very long time: that what looks finished in us is more often buried than gone, and that restoration tends to arrive by removing what piled up rather than by installing something new. Whether you would call that ancient wisdom or you would call it God, it is a strange thing to find the same shape sitting in the knee of an old mouse.
Knees are knees. But it is a reasonable week to be a little slower about deciding what in you is permanent.
A good place to start:
The Beginner’s Guide to Feeling God’s Presence Every Day
A simple 3-step rhythm for noticing God in ordinary moments — the commute, the kitchen, the waiting room, the stairs you have started taking slowly.
Get the free guide
Free.
A question worth arguing about
When a study like this lands, the coverage almost always jumps straight to “cure.” Would you rather hear about research this early — years before anyone can use it — or only once it has actually reached patients? There is a real case for both. Tell us which side you land on in the comments.
Worth sharing
- Cartilage was the textbook example of something that never grows back. Turns out the repair system was fine — an enzyme that doubles with age was shredding the signal. Blocking it regrew real cartilage in old mice. https://bgodinspired.com/index.php/bgodinspired-news/bgodinspired-health-news/can-knee-cartilage-grow-back/
- The part nobody mentions about the Stanford cartilage study: no stem cells. The old worn-out cells in the joint just went back to building. The capacity had been in there the whole time. https://bgodinspired.com/index.php/bgodinspired-news/bgodinspired-health-news/can-knee-cartilage-grow-back/
- Read this before you get excited about the “regrow your cartilage” headline going around again — it worked in mice and in lab tissue, nobody has been treated, and the study is from 2025. Still remarkable. Just not a treatment. https://bgodinspired.com/index.php/bgodinspired-news/bgodinspired-health-news/can-knee-cartilage-grow-back/
Questions People Are Asking
Can knee cartilage grow back?
In humans, not reliably and not on demand — articular cartilage has almost no blood supply, so its natural repair is very limited, which is why severely worn joints are usually replaced rather than repaired. However, a study published in the journal Science by a team led by Stanford Medicine researchers showed that blocking an enzyme called 15-PGDH restored lost cartilage in the knees of aged mice, and produced early signs of new cartilage in human knee tissue treated in a laboratory. No person has been treated with this approach.
What is 15-PGDH and why does it matter for arthritis?
15-PGDH, or 15-hydroxyprostaglandin dehydrogenase, is an enzyme that breaks down prostaglandin E2, a molecule that signals tissue to repair itself. Researchers call it a “gerozyme” because it becomes more abundant with age. In the Stanford-led study, the amount of this enzyme in mouse cartilage roughly doubled between young and old animals, and blocking it allowed the repair signal to persist, which prompted existing cartilage cells to start rebuilding.
Was the cartilage study done with stem cells?
No, and that is one of its most notable features. No stem cells were added. The cartilage cells already present in the ageing joints changed their gene expression and resumed building new tissue. The researchers described this as a new route to regenerating adult tissue, since most regeneration strategies assume worn-out cells must be replaced rather than reactivated.
Is there a treatment available now to regrow knee cartilage?
No. As of October 2026 there is no approved or available treatment that regrows knee cartilage by blocking 15-PGDH, and no human trial has tested it for that purpose. An oral 15-PGDH inhibitor has completed early safety testing in healthy volunteers for an unrelated condition, age-related muscle weakness, and the researchers have expressed hope that this makes a cartilage trial possible in future. Anyone offering such a treatment today is not offering this.
What actually helps knee arthritis pain right now?
Evidence reviews of existing clinical trials consistently point to non-drug measures as the foundation — structured exercise and strengthening, weight management where relevant, and specific physical approaches — alongside whatever pain management a clinician recommends for an individual case. These are far less exciting than a regeneration headline, but they are available today rather than years away.
